Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein

Native apolipoprotein C-III from human plasma. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II. Present in normal plasma at 80-150 µg/ml.

Native apolipoprotein C-III from human plasma. Present in normal plasma at 80-150 µg/ml. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II.

Please refer to vial label for lot-specific concentration.

Toxicity: Standard Handling (A)

In 10 mM NH₄HCO₃, pH 7.4.

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Following initial thaw, aliquot and freeze (-20°C).

Bonnet, E., et al. 2001. J. Clin. Endocrinol. Metab.86, 296.
Hasse, R., et al. 1998. Electrophoresis 9, 569.
Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.